COVID-19 Contributions

Clinical Trials (KCE Trials)
  • COV-AID  (combinations of drugs blocking interleukin 1 and 6)
  • DAWN-plasma (administration of plasma from patients cured of COVID-19 to hospitalized patients)
  • DAWN Camostat (efficacy of Camostat for COVID-19 patients presenting to ambulatory care)
  • CONFIDENT (administration of plasma from patients cured of COVID-19 to intensive care patients)
  • DisCoVeRy (participation in the international study coordinated by INSERM - France)
  • IMCOVAS (assessment of different vaccines schedules for 3 vaccines against COVID-19 (Pfizer, Moderna and AstraZeneca))
Contact
Karin Rondia (FR)
+32 (0)2 287 33 48
+32 (0)475 769 766
ANNUAL REPORT
Published on: 
2021/10/25